Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation
Reportstack, provider of premium market research reports announces the addition of Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation market report to its offering This highly competitive market is saturated with multiple targeted monoclonal Antibody (mAb) therapies and small molecules, yet more of these treatments are expected to enter the market over the next few years. Despite this, the current developmental pipeline is highly innovative beyond these me-too products and incremental innovations and promises a number of first-in-class...
View full press release